Article Text

Download PDFPDF
Original article
Has European Union legislation to reduce exposure to chromate in cement been effective in reducing the incidence of allergic contact dermatitis attributed to chromate in the UK?
  1. S J Stocks1,
  2. R McNamee2,
  3. S Turner1,
  4. M Carder1,
  5. R M Agius1
  1. 1Centre for Occupational and Environmental Health, Health Sciences Group, School of Community-Based Medicine, Faculty of Medical and Human Sciences, The University of Manchester, Manchester, UK
  2. 2Health Sciences Methodology, School of Community-Based Medicine, Faculty of Medical and Human Sciences, The University of Manchester, Manchester, UK
  1. Correspondence to Dr S J Stocks, COEH, 4th Floor Ellen Wilkinson Building, University of Manchester, Oxford Rd, Manchester, M13 9PT, UK; jill.stocks{at}manchester.ac.uk

Abstract

Objective Hexavalent chromate (chromate) in cement is a well-recognised cause of allergic contact dermatitis (ACD). Consequently in January 2005, following European Union legislation (EU Directive 2003/53/EC), the use or supply of cement containing >2 ppm of chromate was prohibited in the UK (COSHH 2004). This analysis of work-related ill-health surveillance aims to evaluate the effectiveness of this legislation.

Method Changes in the incidence of work-related ACD cases returned to The Health and Occupation Reporting network by dermatologists were analysed taking in to account attribution to chromate and occupation.

Results There was a significant decline in the incidence of both ACD attributed to chromate (incidence rate ratio 0.48, 95% CI 0.36 to 0.64) and ACD not-attributed chromate (0.76, 95% CI 0.69 to 0.85) between the time period preceding the EU legislation (2002–2004) and the postlegislation period (2005–2009). However, the decline in ACD attributed to chromate was significantly greater (p=0.006). This decline was further increased in workers potentially exposed to cement (incidence rate ratio 0.37, p=0.001). The majority of the decline in incidence occurred during 2005.

Conclusion The timing of this significant decline in the UK incidence of chromate attributed ACD, and the greater decline in workers potentially exposed to cement strongly suggests that the EU Directive2003/53/EC was successful in reducing exposure to chromate in cement in the UK.

  • Allergic contact dermatitis
  • chromate or chromium
  • CrVI
  • cement
  • European Union legislation
  • construction workers
  • agriculture
  • epidemiology
  • male reproduction
  • health surveillance
  • fertility
  • asthma
  • occupational health practice
  • fitness for work
  • exposure assessment
  • cross-sectional studies
  • sensitisers
  • physical work
  • diabetes mellitus

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding The Health and Occupation reporting network is partly funded by the UK Health and Safety Executive, but the opinions expressed here are solely those of the authors.

  • Competing interests None.

  • Ethics approval Multicentre Research Ethics Committee approval (02/8/72).

  • Provenance and peer review Not commissioned; internally peer reviewed.